Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa

NCT02025868 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

201

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infection

Interventions

BEHAVIORAL: adherence reinforcement
DRUG: Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)

Sponsor

ANRS, Emerging Infectious Diseases